News

Singapore, January 2020 – Singapore med tech start-up, X-ZELL, has been nominated as a Global Finalist for the 2020 Hello Tomorrow Challenge.  Considered one of the world’s leading deep tech start-up competitions, the Challenge was created to celebrate the “best and...

Singapore, November 2019 – On the back of qualifying for the regional final of the prestigious Hello Tomorrow Challenge, X-ZELL has now been selected as one of Hello Tomorrow’s Deep Tech Pioneers. According to the competition’s organising committee, it received a...

Singapore, November 2019 – Less than a year after premiering at Singapore’s MEDLAB Asia exhibition, X-ZELL Cryoimmunostaining™ is now coming to Europe. Originally designed to enable X-ZELL’s headline-making research into next-generation biomarkers, the world’s first...

Singapore, October 2019 – X-ZELL has been nominated as one of 16 regional finalists of the 2019 Hello Tomorrow Singapore Challenge. Hello Tomorrow is a global non-profit organisation on a mission to accelerate deep technology research and entrepreneurship, and to...

Singapore, October 2019 – X-ZELL has been selected as one of the start-ups to be featured on A*ccelerate Technologies’ Innovation Pavilion at the upcoming SWITCH exhibition in Singapore. Short for Singapore Week of Innovation and Technology, SWITCH first came to life...

Singapore/ Essen, October 2019 – German industrial services specialist, Deutsche Industrieanlagen (DIAG), has officially joined X-ZELL’s US$3m Seed+ funding round. Ranked amongst Asia’s 50 most innovative health technology start-ups for two years running, X-ZELL...

Singapore, October 2019 – X-ZELL has been ranked amongst the 50 leading health tech start-ups in Asia for the second year running. Every year, the prestigious list is compiled by Singapore-based analytics and advisory firm, Galen Growth Asia, which has developed a...

Bangkok/Basel, August 2019 (via PR Newswire) – An international research team at Mahidol University in Bangkok, Thailand, has demonstrated the potential for a new blood test to detect clinically significant prostate cancer in high-risk patients, as...

Singapore, July 2019 – Singapore-based rare cell detection specialist, X-ZELL, is about to embark on the most ambitious research and innovation project in the company’s history. Nicknamed Cloud Atlas, the landmark project will consolidate the image material collected...

Singapore, May 2019 – X-ZELL, only recently named one of Asia’s 20 most innovative health tech start-ups, today opened its new global headquarters at Paya Lebar Square in Singapore, conveniently located between Changi Airport and the city's vibrant Central Business...